Apollo Endosurgery, Inc. (APEN) |
| 10 0 (0%) 04-03 16:00 |
| Open: | 9.93 |
| High: | 10 |
| Low: | 9.92 |
| Volume: | 1,639,528 |
| Market Cap: | 580(M) |
| PE Ratio: | -9.43 |
| Exchange: | NASDAQ Global Market |
| Industry: | Medical - Devices |
| Sector: | Healthcare |
| Technical analysis | ||||
![]() |
||||
| sell | buy | |||
| Resistance 2: | 11.68 |
| Resistance 1: | 10.00 |
| Pivot price: | 9.92 |
| Support 1: | 9.91 |
| Support 2: | 9.85 |
| 52w High: | 10.3 |
| 52w Low: | 3.49 |
Apollo Endosurgery, Inc., a medical technology company, focuses on the design, development, and commercialization of medical devices. The company offers OverStitch and OverStitch Sx Endoscopic Suturing Systems that enable advanced endoscopic procedures by allowing physicians to sutures and secure the approximation of tissue through a flexible endoscope. It also provides Orbera, an intragastric balloon system that reduces stomach capacity causing patients to consume less following the procedure, as well as delays gastric content emptying under the Orbera Intragastric Balloon System, BIB, and Orbera365 Managed Weight Loss System brands. Additionally, the company offers X-Tack Endoscopic HeliX Tacking System, a suture-based device for closing and healing defects in the lower and upper gastrointestinal tract. The company sells its products to medical services providers; and hospitals, outpatient surgical centers, clinics, and physicians in the United States, Australia, Costa Rica, and other European countries. Apollo Endosurgery, Inc. was founded in 2005 and is headquartered in Austin, Texas.
| EPS | -1.050 |
| Book Value | 1.020 |
| PEG Ratio | 0.00 |
| Gross Profit | 0.892 |
| Profit Margin (%) | 0.00 |
| Operating Margin (%) | 0.00 |
| Return on Assets (ttm) | 0.0 |
| Return on Equity (ttm) | 0.0 |
Wed, 07 Jan 2026
Med tech company begins renovations for new South Congress offices - Austin American-Statesman
Wed, 26 Apr 2023
Four things to know about our acquisition of Apollo Endosurgery - www.bostonscientific.com
Tue, 04 Apr 2023
Boston Scientific completes $615M acquisition of Austin-based Apollo Endosurgery - Worcester Business Journal
Tue, 04 Apr 2023
Boston Scientific completes Apollo Endosurgery acquisition - MassDevice
Tue, 29 Nov 2022
Boston Scientific enters bariatric market with $417M acquisition of Apollo Endosurgery - BioWorld MedTech
Tue, 29 Nov 2022
Apollo Endosurgery to be Acquired by Boston Scientific - Yahoo Finance
|
StockChart iOS |
StoxlineLite iOS |
StoxlineLite iOS |
OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |